Zobrazeno 1 - 10
of 98
pro vyhledávání: '"[18F]PSMA-1007"'
Autor:
T. L. Antonevskaya, A. I. Khalimon, O. V. Mukhortova, M. M. Khodzhibekova, A. I. Nikiforuk, D. D. Zubkov, G. F. Khamadeeva, D. Yu. Khodakova, T. N. Lazutina, I. V. Pylova, A. V. Leontyev, I. P. Aslanidi
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 11, Iss 2, Pp 8-21 (2024)
Оne of the most commonly used fluorine‑18 labeled prostate-specific membrane antigen (PSMA) ligands in positron emission tomography combined with computed tomography (PET/CT) is [18F]PSMA‑1007. In comparison to other clinically available PSMA ra
Externí odkaz:
https://doaj.org/article/57e22b2b4d1a414e89d5f795f67be8f6
Autor:
Jonas-Alexander Benecke, Eduardo Calderón, Gerald Reischl, Andreas Brendlin, Igor Tsaur, Christian la Fougère, Jonas Vogel
Publikováno v:
Diagnostics, Vol 14, Iss 20, p 2327 (2024)
Background: Focal unspecific bone uptake (UBU) is common in [18F]PSMA-1007 PET/CT, yet its clinical significance remains unclear, causing uncertainty in treatment decisions. Material and Methods: We retrospectively analyzed 99 prostate cancer patient
Externí odkaz:
https://doaj.org/article/240ebf96899247b3bc13e1cec39f002d
Autor:
Miguel Mendoza-Ávila, Hiram Esparza-Pérez, Juan Andrés Castillo-López, Edel Rafael Rodea-Montero
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
PurposeTo determine the agreement between the PSMA-RADS and E-PSMA standardized reporting systems in the classification of [18F]PSMA-1007–uptaking lesions identified on PET/CT scan in patients with prostate cancer (PCa) and post-prostatectomy with
Externí odkaz:
https://doaj.org/article/7fcf0860878d4d049ca85603ac4655bf
Publikováno v:
European Journal of Hybrid Imaging, Vol 7, Iss 1, Pp 1-10 (2023)
Abstract Background [18F]PSMA-1007 is a prostate specific membrane antigen (PSMA) ligand for positron emission tomography (PET) imaging of prostate cancer. Current guidelines recommend imaging 90–120 min after injection but strong data about optima
Externí odkaz:
https://doaj.org/article/d62d42e809cf4c328fd925fa82c470ac
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Venkata Avinash Chikatamarla, Satomi Okano, Peter Jenvey, Alexander Ansaldo, Matthew J. Roberts, Stuart C. Ramsay, Paul A. Thomas, David A. Pattison
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Background Accurate prostate cancer imaging is critical for patient management. Multiple studies have demonstrated superior diagnostic accuracy of [68Ga]-PSMA-11 PET/CT over conventional imaging for disease detection, with validated clinical
Externí odkaz:
https://doaj.org/article/122bdad2ca894c99a57d153a9e677a5b
Autor:
Costantina Maisto, Anna Morisco, Roberta de Marino, Elisabetta Squame, Valentina Porfidia, Laura D’Ambrosio, Daria Di Martino, Paolo Gaballo, Michela Aurilio, Monica Buonanno, Aureliana Esposito, Marco Raddi, Secondo Lastoria
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 6, Iss 1, Pp 1-10 (2021)
Abstract Background Prostate-specific membrane antigen is overexpressed in prostate cancer and it is considered a good target for positron emission tomography/computed tomography imaging of primary cancer and recurrent/metastatic disease, as well as
Externí odkaz:
https://doaj.org/article/e2ca2845be5a47a29b01e368124e5f72
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marina Orevi, Simona Ben-Haim, Galith Abourbeh, Alexandre Chicheportiche, Eyal Mishani, Vladimir Yutkin, Ofer N. Gofrit
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
BackgroundPET-CT using prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals labeled with 68Ga or 18F has emerged as the most sensitive staging tool in prostate cancer (PC). Nonetheless, the occurrence of false positive (FP) findin
Externí odkaz:
https://doaj.org/article/875ff6da2da54eb9bc75955d8c1ce59d
Autor:
Sadahiro Naka, Tadashi Watabe, Kenta Kurimoto, Motohide Uemura, Fumihiko Soeda, Oliver C. Neels, Klaus Kopka, Mitsuaki Tatsumi, Hiroki Kato, Norio Nonomura, Eku Shimosegawa, Jens Cardinale, Frederik L. Giesel, Jun Hatazawa
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 5, Iss 1, Pp 1-17 (2020)
Abstract Background [18F]PSMA-1007, a positron emission tomography (PET) tracer, specifically targets prostate-specific membrane antigen (PSMA), which is highly expressed in prostate cancer. PSMA-PET is effective especially for regional detection of
Externí odkaz:
https://doaj.org/article/79539a886eca4b86840d8eb0fb31065e